Clinical Trial Update: Regulatory T-cells After Subcutaneous Immunotherapy

View source ↗

Summary

A completed clinical trial evaluated regulatory T-cell responses after subcutaneous immunotherapy for grass pollen allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Grass Pollen Allergy

Drugs mentioned

• Grass pollen extract for subcutaneous immunotherapy (grass pollen extract)

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Grass Pollen Allergy, Specific Immunotherapy | Status: COMPLETED